Influence of diabetes mellitus on early and late outcome after percutaneous transluminal coronary angioplasty.

No abstract is available for this paper.

• Publication year

  1995

• Venue

  Circulation

• Publication date

  1995-02-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/01.CIR.91.4.979PMID 7850985
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Nomenclature and Criteria for Diagnosis of Diseases of the Heart and Great Vessels

  1994cited by this paper
• Diabetes, Other Risk Factors, and 12-Yr Cardiovascular Mortality for Men Screened in the Multiple Risk Factor Intervention Trial

  1993cited by this paper
• Restenosis after Arterial Injury Caused by Coronary Stenting in Patients with Diabetes Mellitus

  1993cited by this paper
• Attenuated Fibrinolysis and Accelerated Atherogenesis in Type II Diabetic Patients

  1993cited by this paper
• Can restenosis after coronary angioplasty be predicted from clinical variables?

  1993cited by this paper
• Acute myocardial infarction in the diabetic patient: pathophysiology, clinical course and prognosis.

  1992cited by this paper
• Clinical, physiologic, anatomic and procedural factors predictive of restenosis after percutaneous transluminal coronary angioplasty.

  1991cited by this paper
• Patient-related variables and restenosis after percutaneous transluminal coronary angioplasty--a report from the M-HEART Group.

  1990cited by this paper
• Thromboxane biosynthesis and platelet function in type II diabetes mellitus.

  1990cited by this paper
• 5-year incidence of atherosclerotic vascular disease in relation to general risk factors, insulin level, and abnormalities in lipoprotein composition in non-insulin-dependent diabetic and nondiabetic subjects.

  1990cited by this paper
• Blood Rheology in Diabetes Mellitus

  1990cited by this paper
• Factors influencing the presence or absence of acute coronary artery thrombi in sudden ischaemic death.

  1989cited by this paper
• Repeat percutaneous transluminal coronary angioplasty and predictors of recurrent restenosis.

  1989cited by this paper
• Repeat coronary angioplasty for restenosis: results and predictors of follow-up clinical events.

  1989cited by this paper
• Characterization of Induction of Protooncogene c-myc and Cellular Growth in Human Vascular Smooth Muscle Cells by Insulin and IGF-I

  1989cited by this paper
• Risk factors for recurrent stenosis following successful coronary angioplasty.

  1989cited by this paper
• Restenosis after successful percutaneous transluminal coronary angioplasty: serial angiographic follow-up of 229 patients.

  1988cited by this paper
• Multiple coronary angioplasty: a model to discriminate systemic and procedural factors related to restenosis.

  1988cited by this paper
• Incidence of restenosis after successful coronary angioplasty: a time-related phenomenon. A quantitative angiographic study in 342 consecutive patients at 1, 2, 3, and 4 months.

  1988cited by this paper
• Multilesion coronary angioplasty: clinical and angiographic follow-up.

  1987cited by this paper
• Alterations in left ventricular diastolic function with doxorubicin therapy.

  1987cited by this paper
• Multiple vessel coronary angioplasty: classification, results, and patterns of restenosis in 494 consecutive patients.

  1987cited by this paper
• Factors of the hemostatic system in diabetic patients. A survey of controlled studies.

  1986cited by this paper
• PARD: platelet aggregation as a risk factor in diabetics: results of a prospective study.

  1985cited by this paper
• Restenosis after percutaneous transluminal coronary angioplasty (PTCA): a report from the PTCA Registry of the National Heart, Lung, and Blood Institute.

  1984cited by this paper
• Status of the coronary arteries at necropsy in diabetes mellitus with onset after age 30 years. Analysis of 229 diabetic patients with and without clinical evidence of coronary heart disease and comparison to 183 control subjects.

  1980cited by this paper
• Diabetes and cardiovascular disease. The Framingham study.

  1979cited by this paper
• Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. National Diabetes Data Group.

  1979cited by this paper
• Letter: Grading of angina pectoris.

  1976cited by this paper
• Growth of Rabbit Aortic Smooth-Muscle Cells Cultured in Media Containing Diabetic and Hyperlipemic Serum

  1976cited by this paper
• Regression Models and Life-Tables

  1972cited by this paper
• Platelets, Coagulation and Fibrinolysis in Diabetic and Non-Diabetic Patients with Quiescent Coronary Heart Disease

  1970cited by this paper
• Atherosclerosis in persons with hypertension and diabetes mellitus.

  1968cited by this paper
• Atherosclerosis in persons with hypertension and diabetes mellitus.

  1968cited by this paper
• Statistical aspects of the analysis of data from retrospective studies of disease.

  1959cited by this paper
• Nonparametric Estimation from Incomplete Observations

  1958cited by this paper

• Clinical outcomes of percutaneous coronary intervention in chronic total occlusion in patients with type 2 diabetes mellitus.

  2023cites this paper
• Effect of the Ligation and Reperfusion Timeframe on Maximal Ischemia-Reperfusion Injury in Diverse Rat Models.

  2023cites this paper
• Percutaneous Revascularisation in Diabetic Patients with Coronary Artery Percutaneous Revascularisation in Diabetic Patients with Coronary Artery Disease Disease

  2023cites this paper
• Comparison of Long-term Outcome between Diabetic and Non-Diabetic Patients with Ischemic Heart Disease following Percutaneous Coronary Intervention: A Prospective Study

  2022cites this paper
• Diabete e cardiopatia ischemica

  2021cites this paper
• Short- and long-term cardiovascular outcomes in insulin-treated versus non-insulin-treated diabetes mellitus patients after percutaneous coronary intervention: A systematic review and meta-analysis

  2021cites this paper
• Drug-Coated Balloon-Only Angioplasty Outcomes in Diabetic and Nondiabetic Patients with De Novo Small Coronary Vessels Disease

  2021cites this paper
• Comparison of Long-Term Outcomes After Percutaneous Coronary Intervention in Patients With Insulin-Treated vs. Non-Insulin Treated Diabetes Mellitus.

  2021cites this paper
• The Association between Type-2 Diabetes Duration and Major Adverse Cardiac Events after Percutaneous Coronary Intervention

  2021cites this paper
• Impact of diabetes mellitus on vascular healing process after everolimus-eluting stent implantation: An optical coherence tomography study.

  2021cites this paper
• Diabetes and periprocedural outcomes in patients treated with rotablation during percutaneous coronary interventions.

  2020cites this paper
• HbA1c as a Predictor of Postoperative Infection in Type 2 Diabetic Patients after Coronary Artery Bypass Grafting

  2020cites this paper
• Durable polymer everolimus-eluting stents: history, current status and future prospects

  2020cites this paper
• Diabetes Mellitus and Coronary Artery Disease

  2020cites this paper
• Prozedurale Komplikationen

  2020cites this paper
• Longitudinal neointimal distribution pattern after Everolimus-eluting stent implantation: Insights from optical coherence tomography study.

  2020cites this paper
• Angiographic Pattern of Coronary Artery Disease in Diabetic Patients Having Abnormal Ankle Brachial Index

  2019cites this paper
• In-Hospital Outcome of Patients with Diabetes Mellitus after CTO Recanalization with Third-Generation Drug-Eluting Stents

  2019cites this paper
• Efficacy and safety of drug-eluting stenting compared with bypass grafting in diabetic patients with multivessel and/or left main coronary artery disease

  2019cites this paper
• Quality of life at six months after primary percutaneous coronary intervention performed at a predominantly rural population

  2019cites this paper
• Diabetes and Cardiovascular Diseases ( VII ) Coronary Angioplasty in Diabetic Patients . Current and Future Perspectives

  2019cites this paper
• Coronary angiography in the very old: impact of diabetes on long-term revascularization and mortality

  2019cites this paper
• Clinical outcomes of percutaneous coronary intervention with drug eluting stents in diabetic patients

  2018cites this paper
• Merging the properties of a sirolimus coated balloon with those of a bioresorbable polymer sirolimus eluting stent to address the "diabetes issue". Results from the En-Abl multicenter registry.

  2018cites this paper
• Functional differences between healthy and diabetic endothelial cells on topographical cues.

  2018cites this paper
• Impact of diabetes mellitus in patients undergoing contemporary percutaneous coronary intervention: Results from a Korean nationwide study

  2018cites this paper
• Graphene oxide: Nylon ECG sensors for wearable IoT healthcare—nanomaterial and SoC interface

  2018cites this paper
• Challenges in Patients with Diabetes: Improving Clinical Outcomes After Percutaneous Coronary Intervention Through EVOlving Stent Technology

  2018cites this paper
• Chapter 5 Cardiovascular Disease and Diabetes : Two Sides of the Same Coin !

  2018cites this paper
• Prognostic Relation Between Severity of Diabetes Mellitus (On or Off Insulin) ± Chronic Kidney Disease with Cardiovascular Risk After Percutaneous Coronary Intervention.

  2018cites this paper
• Challenges in Patients with Diabetes: Improving Clinical Outcomes After Percutaneous Coronary Intervention Through EVOlving Stent Technology.

  2017cites this paper
• Efficacy and safety of everolimus and zotarolimus-eluting stents versus first-generation drug-eluting stents in patients with diabetes: A meta-analysis of randomized trials.

  2017cites this paper
• Percutaneous coronary interventions in diabetics: The never‐ending challenge

  2017cites this paper
• Percutaneous Coronary Intervention versus Coronary Artery Bypass Grafting in Patients with Diabetic Nephropathy and Left Main Coronary Artery Disease.

  2017cites this paper
• Comparison of very long-term clinical and angiographic outcomes of bare metal stent implants between patients with and without type 2 diabetes.

  2017cites this paper
• Graphene oxide — Nylon ECG sensors for wearable IoT healthcare

  2017cites this paper
• Clinical Outcomes after Triple Vessel Angioplasty in Diabetic Patients with Triple Vessel Coronary Artery Disease

  2017cites this paper
• Sex‐gender‐related therapeutic approaches for cardiovascular complications associated with diabetes

  2017cites this paper
• Off-pump versus on-pump coronary artery bypass grafting in patients with diabetes: a meta-analysis

  2017cites this paper
• The effects of a growth hormone-releasing hormone antagonist and a gastrin-releasing peptide antagonist on intimal hyperplasia of the carotid artery after balloon injury in a diabetic rat model

  2017cites this paper
• Cardiovascular Disease and Diabetes: Two Sides of the Same Coin!

  2017cites this paper
• TNF Receptor 1/2 Predict Heart Failure Risk in Type 2 Diabetes Mellitus Patients.

  2017cites this paper
• Body Mass Index Is Associated With Differential Rates of Coronary Revascularization After Cardiac Catheterization.

  2017cites this paper
• Glycemic Control in Coronary Revascularization

  2016cites this paper
• Revascularization Strategies in Patients with Diabetes Mellitus and Acute Coronary Syndrome

  2016cites this paper
• Hypertension and Diabetes: Need for Combination Therapy

  2016cites this paper
• Differences in the prognostic relevance of myocardial ischaemia and scar by cardiac magnetic resonance in patients with and without diabetes mellitus.

  2016cites this paper
• Acute Coronary Syndrome, Myocardial Infarction, Heart Failure, and Stable Coronary Artery Disease—Specific Considerations in Diabetes

  2016cites this paper
• Nanopolymer Scaffolds as Novel Carriers for Cells and Drugs

  2016cites this paper
• Percutaneous Coronary Intervention in Patients With Insulin-Treated and Non-Insulin-Treated Diabetes Mellitus: Secondary Analysis of the TUXEDO Trial.

  2016cites this paper
• ntracoronary Brachytherapy After tenting De Novo Lesions in Diabetic Patients esults of a

  2016cites this paper
• Permanent work disability in patients ⩽50 years old after percutaneous coronary intervention and coronary artery bypass grafting (the CRAGS study)

  2016cites this paper
• The impact of a 600-mg loading dose of clopidogrel in diabetic and non-diabetic patients undergoing elective PCI.

  2016cites this paper
• Coronary Revascularisation in Diabetic Patients with Multivessel Disease:Coronary Artery Bypass Grafting versus Percutaneous Coronary Intervention

  2016cites this paper
• Effect of multiple clinical factors on recurrent angina after percutaneous coronary intervention

  2016cites this paper
• Sulfonylurea Drugs Inhibit Membrane-Associated Potassium Channels in Pancreas and Heart

  2016cites this paper
• Outcomes of Coronary Angioplasty in Diabetic Patients – A Retrospective Study

  2016cites this paper
• Comparison of bypass surgery and drug-eluting stenting in diabetic patients with left main and/or multivessel disease: A systematic review and meta-analysis of randomized and nonrandomized studies.

  2015cites this paper
• Comparing of Light Transmittance Aggregometry and Modified Thrombelastograph in Predicting Clinical Outcomes in Chinese Patients Undergoing Coronary Stenting with Clopidogrel

  2015influential citation
• Improving diabetes diagnosis and management in myocardial infarction patients: overcoming clinical inertia

  2015cites this paper
• Clinical features and treatment of coronary heart disease in diabetes

  2015cites this paper
• Type 2 diabetes mellitus

  2015cites this paper
• Systematic Review of Therapies for Stable Coronary Artery Disease in Diabetic Patients.

  2015cites this paper
• Chapter 26 – Chest Pain: General Considerations

  2015cites this paper
• Adverse cardiovascular outcomes between insulin-treated and non-insulin treated diabetic patients after percutaneous coronary intervention: a systematic review and meta-analysis

  2015cites this paper
• Cardiopathie ischémique et infarctus chez le diabétique

  2015cites this paper
• Drug-eluting stents with biodegradable polymer for the treatment of patients with diabetes mellitus: clinical outcome at 2 years in a large population of patients

  2015cites this paper
• Clinical influence of early follow-up glycosylated hemoglobin levels on cardiovascular outcomes in diabetic patients with ST-segment elevation myocardial infarction after coronary reperfusion

  2015cites this paper
• Impact of Modifiable Cardiovascular Risk Factors on Mortality After Percutaneous Coronary Intervention

  2015cites this paper
• PREDISPOSANT FACTORS FOR INTIMAL HYPERPLASIA AND THEIR MECHANISMS OF ACTION IN OPEN VASCULAR SURGERY. A REVIEW.

  2015cites this paper
• Comparison of 12-month clinical outcomes in diabetic and nondiabetic patients with chronic total occlusion lesions: a multicenter study

  2015cites this paper
• Increased prevalence of psoriasis in patients with coronary artery disease: results from a case–control study

  2014cites this paper
• Inflammatory unbalance of TLR3 and TLR4 in PCI patients with or without type 2 diabetes mellitus.

  2014cites this paper
• Effectiveness of Cardiac Rehabilitation for Patients With Cardiac Disease Undergoing Coronary Artery Bypass Graft (CABG)

  2014cites this paper
• Comparing coronary artery bypass grafting with drug-eluting stenting in patients with diabetes mellitus and multivessel coronary artery disease: a meta-analysis.

  2014cites this paper
• Safety and Efficacy of Sirolimus-Eluting Stent in Diabetic Patients Compared with Non-Diabetic Patients Undergoing Percutaneous Coronary Intervention

  2014cites this paper
• Prolonged effectiveness of coronary artery bypass surgery versus drug-eluting stents in diabetics with multi-vessel disease: an updated systematic review and meta-analysis.

  2014cites this paper
• Surgical Versus Percutaneous Revascularization in Patients with Multivessel Coronary Artery Disease

  2014cites this paper
• Protective effect of pre-infarction angina on microvascular obstruction after primary percutaneous coronary intervention is blunted in humans by cardiovascular risk factors.

  2014cites this paper
• Myocardial revascularization strategies in diabetic patients with multi-vessel disease: CABG vs DES-based PCI.

  2014cites this paper
• Meta-analysis of 14 trials comparing bypass grafting vs drug-eluting stents in diabetic patients with multivessel coronary artery disease.

  2014cites this paper
• CORONARY ARTERY DISEASE Original Studies Intimal Hyperplasia and Vascular Remodeling After Everolimus-Eluting and Sirolimus-Eluting Stent Implantation in Diabetic Patients: The Randomized Diabetes and Drug-Eluting Stent (DiabeDES) IV Intravascular Ultrasound Trial

  2014influential citation
• Association Between Hyperglycemia at Admission During Hospitalization for Acute Myocardial Infarction and Subsequent Diabetes: Insights From the Veterans Administration Cardiac Care Follow-up Clinical Study

  2014cites this paper
• Asociación entre enfermedad metabólica y severidad de aterosclerosis coronaria evaluada por Score de Gensini

  2014cites this paper
• Vascular Complications of Diabetes Mellitus

  2014cites this paper
• Disparity in coronary artery diameter in diabetic and non-diabetic subjects undergoing percutaneous coronary intervention in Bangladesh: A 2 years retrospective analysis

  2014cites this paper
• Elevated small dense low-density lipoprotein cholesterol as a predictor for future cardiovascular events in patients with stable coronary artery disease.

  2014cites this paper
• Echocardiographic predictors for recurrence of ischemic mitral regurgitation after restrictive annuloplasty

  2013cites this paper
• Percutaneous coronary intervention in diabetic patients: should choice of stents be influenced?

  2013cites this paper
• Revascularization strategies in patients with Type 2 diabetes mellitus

  2013cites this paper
• Clinical efficacy and safety of biodegradable polymer‐based sirolimus‐eluting stents in patients with diabetes mellitus insight from the 4‐year results of the create study

  2013influential citation
• Epicardial Coronary Arteries in Khat Chewers Presenting with Myocardial Infarction

  2013cites this paper
• 2012 ACCF/AHA focused update incorporated into the ACCF/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.

  2013cites this paper
• Impact of diabetes on long-term mortality following multivessel percutaneous interventions: an insight into optimal statistical analysis.

  2013cites this paper
• The effect of doubling the dose of acetylsalicylic acid (ASA) on platelet function parameters in patients with type 2 diabetes and platelet hyperreactivity during treatment with 75 mg of ASA: a subanalysis of the AVOCADO study.

  2013cites this paper
• Differential long‐term outcomes of zotarolimus‐eluting stents compared with sirolimus‐eluting and paclitaxel‐eluting stents in diabetic and nondiabetic patients: Two‐year subgroup analysis of the ZEST randomized trial

  2013cites this paper
• Diabetic cardiomyopathy—What do we know about it?

  2013influential citation
• Safety and efficacy of everolimus‐eluting stents versus paclitaxel‐eluting stents in a diabetic population

  2013cites this paper
• Comparison of clinical outcomes between first-generation and second-generation drug-eluting stents in type 2 diabetic patients

  2013cites this paper
• [Glycaemic management in type 1 and 2 diabetes patients undergoing interventional cardiology procedures. Heart and Diabetes Working Group. Sociedad Espan˜ola de Cardiologı´a. Sociedad Espan˜ola de Diabetes].

  2012cites this paper